Francisco Folgar, MD
Ophthalmology · Mount Pleasant, SCNPI 1801060454
Payments from drug & device makers
Across 522 payments — averaging $556.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$214K
- Roche TCRC, Inc.$28K
- Apellis Pharmaceuticals, Inc.$20K
- Notal Vision, Inc.$14K
- AbbVie$6K
- Regeneron$3K
- plus $5K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 24 | $214,153 |
| Roche TCRC, Inc. | 2 | $28,367 |
| Apellis Pharmaceuticals, Inc. | 18 | $20,090 |
| Notal Vision, Inc. | 390 | $14,058 |
| AbbVie(2 entities) | 20 | $5,623 |
| Regeneron | 1 | $3,475 |
| Novartis | 10 | $2,396 |
| Astellas Pharma US Inc | 8 | $445 |
| Alcon | 8 | $403 |
| Harrow Eye, LLC | 5 | $330 |
| Genentech USA, Inc. | 9 | $327 |
| Dutch Ophthalmic, USA | 1 | $174 |
| Regeneron Healthcare Solutions, Inc. | 6 | $143 |
| Eyepoint US, Inc. | 2 | $130 |
| Aerie Pharmaceuticals, Inc. | 1 | $112 |
| Alimera Sciences, Inc. | 5 | $106 |
| Bausch & Lomb Americas Inc. | 3 | $73 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $36 |
| Coherus Oncology, Inc. | 1 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| Biogen | 1 | $27 |
| Omeros Corporation | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Rayner Intraocular Lenses Limited | 1 | $20 |
| Dompe US, Inc. | 1 | $16 |
How this compares
$290,607 in reported general payments places this provider in the 95th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Mount Pleasant
- Michael DecourceyMount Pleasant$14K
- Charlene GriceMount Pleasant$7K
- John WellsWest Columbia$7.1M
- William ClarkWest Columbia$6.2M
- Daniel AlfaroCharleston$4.6M
- Kerry SolomonMt Pleasant$4.6M
- Eric JablonCharleston$1.2M
- George WaringMt Pleasant$1M
- John KerrisonCharleston$975K
- Karolinne RochaCharleston$799K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.